MIR100HG

Across TCGA pan-cancer cohorts, MIR100HG RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of MIR100HG’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where MIR100HG RNA is repressed in tumor relative to normal tissue. In most cancer types MIR100HG is over-expressed in tumor, although a few such as BLCA and UCEC show the opposite, repressed pattern.

BLCA, UCEC, and LUSC are the cancer types where MIR100HG tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR100HG RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	All	−3.234	<.001	11	view →
UCEC	All	All	−2.190	<.001	8	view →
LUSC	Female	All	−1.329	<.001	8	view →
KIRP	All	All	−0.748	<.001	8	view →
KIRC	All	II,III,IV	−0.525	<.001	8	view →
BRCA	All	III,IV	−1.511	<.001	6	view →
COAD	All	II,III,IV	−0.778	<.001	6	view →
THCA	All	All	+0.463	<.001	5	view →
STAD	All	All	−1.162	.008	4	view →
HNSC	All	All	−0.425	.016	3	view →
READ	Female	All	−1.888	.030	2	view →
PRAD	All	All	−0.981	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

MIR100HG–BLCA

Open the BLCA breakdown →